Fluid Flow Optimization Systems for Industrial Processes

Publication ID: 24-11857407_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Fluid Flow Optimization Systems for Industrial Processes,” Published Technical Disclosure No. 24-11857407_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857407_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,407.

Summary of the Inventive Concept

This inventive concept leverages the core technology of implantable intraluminal devices to optimize fluid flow in various industrial processes, enhancing efficiency and reducing costs.

Background and Problem Solved

The original patent addressed implantable medical devices for bodily cavities, organs, and vessels. However, industrial processes, such as chemical plants, oil wells, and HVAC systems, face distinct fluid flow challenges. Current solutions often result in clogging, pressure drops, and inefficient flow rates. This inventive concept adapts the stent graft technology to tackle these specific problems, providing a novel solution for industrial fluid flow optimization.

Detailed Description of the Inventive Concept

The inventive concept involves deploying stent graft devices in industrial pipelines, ducts, or wells. Each device features multiple tubular segments, each with an individual annular stent member and a tubular membrane. At least one flow channel is disposed at the peripheral wall of the stent graft device, enabling fluid communication and flow control. The system can be configured to monitor and control fluid flow, optimize flow rates, and reduce pressure drops. In oil wells, the system prevents clogging, while in HVAC systems, it reduces pressure drop and improves efficiency.

Novelty and Inventive Step

The inventive concept's novelty lies in its application of stent graft technology to industrial fluid flow optimization, addressing a previously unexplored field. The inventive step resides in the adaptation of the original patent's design to accommodate the unique demands of industrial processes, such as high-pressure and high-flow rate environments.

Alternative Embodiments and Variations

Alternative embodiments may include using different materials for the stent graft device, varying the number and configuration of tubular segments, or integrating sensors and actuators for real-time flow control. Variations could also involve applying this technology to other industrial processes, such as water treatment or food processing.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including chemical processing, oil and gas, HVAC, and agriculture. By optimizing fluid flow, companies can reduce energy consumption, increase efficiency, and minimize downtime. The market for industrial fluid flow optimization solutions is substantial, with potential applications in new installations, retrofits, and aftermarket services.

CPC Classifications

SectionClassGroup
A A61 A61F2/07
A A61 A61F2/04
A A61 A61F2/852
A A61 A61F2/88
A A61 A61F2/89
A A61 A61F2002/041
A A61 A61F2002/075
A A61 A61F2240/001
A A61 A61F2250/0065
Y Y10 Y10T29/49826

Original Patent Information

Patent NumberUS 11,857,407
TitleImplantable intraluminal device
Assignee(s)W. L. Gore & Associates, Inc.